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Bioactive synthetic hydrogels have emerged as promising materials because they 
can provide molecularly tailored biofunctions and adjustable mechanical properties. To 
mimic the mineralogical and organic components of the natural bone, hydroxyapatite and 
a tyramine conjugate of gelatine were combined in this study. The effect of various 
amounts of in situ synthesized hydroxyapatite in gelatine-tyramine on the morphology 
and physical properties of injectable hydrogels was investigated. Mineralogical identifi-
cation confirmed successful precipitation of in situ formed hydroxyapatite. Better distri-
bution of hydroxyapatite crystal agglomerates within modified gelatine was found at 5 % 
of hydroxyapatite, which could be responsible for increased storage modulus with re-
spect to pure gelatine hydrogel. Prepared composite hydrogels are non-toxic and support 
the proliferation of Hek293 cells.
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Introduction
Hydrogels (i.e., three-dimensional cross-linked 
hydrophilic polymer networks containing a high 
quantity of water), have received considerable at-
tention in the past decades in a wide range of appli-
cations. They possess a degree of flexibility very 
similar to natural tissue due to their large water con-
tent1. In the swollen state, hydrogels are soft and 
rubbery, resembling the living tissue, which opens 
up many opportunities for biomedical aplications. 
In particular, in situ gelling hydrogels have attracted 
attention for drug delivery application and tissue re-
generation2. In situ gelling hydrogels are attractive 
because they can fill any shape of a defect, allow 
homogeneous incorporation of therapeutic mole-
cules or cells, and require no surgical procedures 
for implantation3.
Gelatine-based hydrogels have been extensive-
ly studied due to their low cost, biodegradability, 
biocompatibility, and non-immunogenic properties. 
A gelatine physical hydrogel is formed at tempera-
tures below 25 °C. When the temperature is raised 
above approximately 30 °C, gelatine is in the liquid 
state, thus limiting its use in tissue regeneration. To 
avoid dissolution at body temperature, chemical 
crosslinkers as glutaraldehyde, genipin, carbodiim-
ides, etc., have been used. A drawback of those 
crosslinkers is their potential cytotoxicity. Recently, 
gelatine-tyramine conjugates have been proposed as 
injectable hydrogels as they form stable hydrogels 
under a non-cytotoxic enzymatically catalysed reac-
tion in the presence of small amounts of hydrogen 
peroxide3.
Modified gelatine using tyramine grafting has 
been mostly used as a soft tissue substituent encap-
sulating cells, mainly for cartilage defects. Several 
works have been focused on improving the mechan-
ical and biological properties of gelatine-tyramine 
based hydrogels, introducing polymer fibres4 or 
other natural polymers, such as hyaluronic acid5,6. 
Poveda-Reyes et al.4 modified gelatine-tyramine 
enzymatically crosslinked hydrogel by adding PHE-
MA-grafted PLLA fibres, which resulted in almost 
3-fold increase in shear storage modulus. The PHE-
MA-grafting of PLLA ensured good interfacial in-
teractions between PLLA microfibers and gelatine 
matrix without affecting the enzymatic crosslinking 
of the hydrogel.*Corresponding author: E-mail: arogina@fkit.hr, ggallego@ter.upv.es
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The same group6 combined tyramine conju-
gates of gelatine and hyaluronic acid, in different 
proportions, in order to mimic extracellular matrix. 
Depending on the gelatine/hyaluronic acid ratio, 
 injectable hydrogels showed improved mechanical 
stability and enhanced expression of aggrecan, col-
lagen type II and GAG of encapsulated human mes-
enchymal stem cells without using the supplement 
of growth factors.
The enzymatic crosslinking of gelatine-tyra-
mine has proved to be suitable for cell encapsula-
tion and regeneration of soft tissues like cartilage; 
however, few attempts have been made in the mod-
ification of gelatine-tyramine osteoconductive prop-
erties using bioactive inorganic components (such 
as calcium phosphates). Bone tissue is a composite 
material consisting of organic (mostly collagen) and 
inorganic (calcium phosphates, mostly hydroxyapa-
tite) components. To mimic the natural bone, Thinh 
et al.7 prepared injectable hydrogels based on mod-
ified chitosan (chitosan-4 hydroxyphenylacetamide 
acid), gelatine-tyramine, and biphasic calcium 
phosphate nanoparticles (BCP NPs). Those gels ex-
hibited very fast gelation ranging from 35 to 80 sec-
onds, depending on the concentration of H2O2. They 
reported slower in vitro biodegradation in the pres-
ence of 10 % of BCP NPs within composite hydro-
gel. The same group8 introduced calcium phosphate 
nanoparticles in gelatine-PEG modified hydrogel in 
order to enhance hydrogels bioactivity and biode-
gradability by varying the amount of BCP. They re-
ported that higher surface roughness, originated 
from BCP, stimulates the attachment of MG-63 
cells.
However, those gelatine-based hydrogels load-
ed with BCP nanoparticles were obtained by con-
ventional mechanical mixing of previously synthe-
sized inorganic phase. The blending of particles into 
polymer usually results in particle agglomeration 
due to the higher cohesion, which affects the final 
mechanical and surface properties. Moreover, it is 
difficult to avoid the precipitation of mixed inor-
ganic particles previously to gelatine crosslinking.
According to the literature, no attempts have 
been made in developing an injectable gelatine/
HAp material. Bearing this in mind, we proposed 
injectable gelatine-based composite hydrogels with 
in situ formed hydroxyapatite (HAp; 
Ca10(PO4)6(OH)2), mimicking the nanocrystallinity 
of natural tissue. To our knowledge, this is the first 
time to synthesize a nanostructured gelatine-tyra-
mine/HAp injectable hydrogel via in situ precipita-
tion of hydroxyapatite. It is hypothesized that func-
tional carboxylic groups of gelatine could serve as 
specific nucleation sites for guided apatite crystalli-
sation, leading to a formation of homogeneous 
nanostructured composite material. To avoid possi-
ble toxicity of final hydrogel, calcium carbonate as 
a non-toxic calcium precursor for HAp, would pro-
vide in situ synthesis of a more bioactive apatite 
phase, similar to the biological one (carbonated hy-
droxyapatite). Therefore, different gelatine/HAp hy-
drogels were prepared in order to investigate the 
optimal composition in terms of HAp particles dis-
tribution within the hydrogel.
Materials and methods
Preparation of tyramine conjugated gelatine
The gelatine (from porcine skin type A, gel 
strength 300, 80 mmol of COOH per 100 g of gela-
tine; Sigma-Aldrich, Germany) was modified by 
grafting the amino groups of tyramine (tyramine 
hydrochloride, ≥98 %; Sigma-Aldrich, Germany) to 
the carboxylic groups of gelatine, via the carbo-
diimide-mediated condensation, as shown in Fig. 1. 
The molar ratios for the grafting were tyra-
mine/N-(3-dimethylaminopropyl)-N’-ethylcarbo-
diimide hydrochloride (EDC; Iris Biotech GmbH, 
Marktredwitz, Germany)/COOH = 2/2/1 and N-hy-
droxysuccinimide (NHS, 98 %; Sigma-Aldrich, 
Germany)/EDC = 1/10. Briefly, 3 % (w/v) of gela-
tine was dissolved in 50 mmol L–1 2-(N-morpholi-
no)ethanesulfonic acid (MES, >99 %; Sigma-Al-
drich, Germany) at 60 °C for 30 min under stirring 
(0.6 g of gelatine and 0.195 g of MES in 20 mL). 
An amount of 0.111 g of tyramine hydrochloride 
was then added and the mixture was stirred for 20 
min at room temperature. The pH was adjusted to 6. 
After that, 7 mg of NHS was added and homo-
genised by stirring for 30 min. Finally, 123 mg of 
EDC was added to the mixture and stirred for an-
other 24 h at 37 °C. Unreacted reagents were re-
moved via dialysis against deionised water for 48 h. 
The modified gelatine was frozen under liquid ni-
trogen and kept overnight at –80 °C. Frozen gela-
tine was then lyophilised under vacuum (p < 1 
mbar) at –100 °C for two days. Lyophilised gelatine 
was denoted as ‘Gel-Tyr’.
Synthesis of hydroxyapatite particles as a 
control material
Hydroxyapatite particles were synthesized as a 
control for further identification and characterisa-
tion. Hydroxyapatite was prepared by the wet chem-
ical precipitation method using calcite (CaCO3; 
TTT, Croatia) and urea phosphate ((NH2)2CO–
H3PO4, UPH; Aldrich Chemistry, USA) as precursor 
materials. Specific amount of calcite as a source of 
calcium ions was added to 100 mL of distilled wa-
ter followed by the addition of UPH with respect to 
the Ca/P ratio of 1.67. Temperature was set at 50 °C 
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and stirring continued for 4 days. Obtained precipi-
tate suspension was filtered, washed three times 
with distilled water, and left to dry at room tem-
perature.
In situ synthesis of hydroxyapatite in tyramine 
modified gelatine solution
The gelatine-tyramine/hydroxyapatite (Gel-
Tyr/HAp) composite was prepared by the in situ 
wet precipitation method. Starting 3 % (w/v) Gel-
Tyr solution was prepared by dissolving gelatine-ty-
ramine lyophilised powder in deionised water (pH 
of 7) at 37 °C. The specific amount of calcite was 
then added into the polymer solution with rigorous 
stirring at 1700 rpm at 37 °C. When homogeneous 
gelatine-tyramine/calcite suspension was achieved, 
appropriate amount of UPH with respect to the Ca/P 
ratio of 1.67 was added into the mixture. The reac-
tion temperature was set at 50 °C, and the solution 
was stirred for 24 hours. The final suspension was 
cooled to room temperature, and subsequently fro-
zen with liquid nitrogen, stored at –80 °C overnight, 
and lyophilised according to the previously de-
scribed procedure. The hydroxyapatite content in 
final Gel-Tyr/HAp composites was set to 2, 5, and 
10 % (w/w), and composites were denoted as 2 % 
HAp, 5 % HAp, and 10 % HAp, respectively.
Injectable composite hydrogel preparation
To prepare the composite gelatine-tyramine/hy-
droxyapatite hydrogel, enzymatic crosslinking was 
performed (Fig. 1) using 20 U mL–1 of horseradish 
peroxidase (HRP, type I, Sigma-Aldrich, Germany) 
(1:10 ratio of HRP: hydrogel volume), and 10 mmol L–1 
H2O2 solution (Sigma-Aldrich, Germany) (1:10 ratio 
of HRP: hydrogel volume). The mixture was then 
quickly stirred (5 sec at 1000 rpm on Vortex) to ob-
tain a homogeneous solution which allowed forma-
tion of a hydrogel at room temperature in a few 
minutes. After crosslinking, the samples were 
F i g .  1  – Illustration of hydrogel synthesis performed in three steps: a) tyramine grafting on carboxylic group of gelatine; b) in situ 
precipitation of hydroxyapatite within Gel-Tyr solution from calcium and phosphate precursors; c) enzymatic crosslinking 
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washed with deionised water, lyophilised according 
to the previously described procedure, and stored 
for further characterisation.
Characterisation of materials
Proton nuclear magnetic resonance and  
UV spectrophotometer
The measurements were performed as a part of 
previous research4. 1H-NMR measurements were 
performed in D2O for the gelatine and the tyramine 
grafted gelatine at a concentration of 10 mg mL–1 in 
a Spectra spin400 Ultra shield from Bruker. To de-
termine the quantity of phenol (Ph) groups intro-
duced in the gelatine, the absorbance of a 0.1 % 
(w/w) aqueous solution of the grafted gelatine was 
analysed at 275 nm with a CECIL CE9200 UV/VIS 
double beam spectrophotometer (Buck Scientific, 
Norwalk, USA).
Fourier transform infrared spectroscopy
All prepared samples were characterised using 
Fourier transform infrared spectroscopic analysis 
(FTIR). FTIR spectra were recorded by ATR-FTIR 
Bruker Vertex 70 spectrometer with a diamond cry-
stal, 16 times in the absorption mode in the range of 
4000 – 400 cm–1 with a resolution of 4 cm–1 at 20 °C.
X-ray diffraction analysis
The mineralogical composition of prepared 
materials was determined by X-ray diffraction 
 analysis (XRD) on a Shimadzu XRD 6000 instru-
ment with Cu Ka radiation at 40 kV and 30 mA, at 
angle range of 5° < 2θ < 70°, and with a scan rate 
of 0.2° s–1. The identification of the crystal phase 
was carried out using ICDD database (The Interna-
tional Centre for Diffraction Data).
Scanning electron microscopy
Prior to imaging, all samples were shock-fro-
zen in liquid nitrogen, quickly transferred to a 
freeze-drier, and lyophilised for 72 h. The morphol-
ogy of lyophilised hydrogels was imaged by scan-
ning electron microscopy (SEM) on a TESCAN 
Vega3SEM EasyProbe microscope with electron 
beam energy of 10 kV. Prior to scanning, the sam-
ples were sputtered with gold and palladium for 120 
seconds.
Equilibrium water content
The swelling capacity of hydrogels was evalu-
ated in deionised water. Crosslinked samples were 
immersed in deionised water for 2 h at room tem-
perature. The swollen hydrogels were removed 
from the immersion medium, the water excess was 
absorbed by a filter paper, and hydrogels were 
weighed (wwet). Swollen samples were frozen in liq-
uid nitrogen, stored at –80 ºC overnight, and lyoph-
ilised to determine their dry weight (wdry). The equi-
librium water content (EWC) was determined by 
Equation 1:
 ( ) wet dry
dry




= ⋅  (1)
Rheological properties
The rheological characterisation of hydrogels 
was carried out by a Discovery HR-2 Hybrid Rhe-
ometer (TA Instruments) using a parallel plates ge-
ometry of 20 mm diameter, and a gap between the 
plates of about 900 μm. The measurements were 
taken at 25 °C using a solvent trap to avoid water 
evaporation from the hydrogels during the experi-
ment.
An amplitude test of crosslinked hydrogel was 
carried out at deformation range of 0.01 to 100 % 
and frequency of 1.26 rad s–1 to determine linear 
viscoelastic region of the hydrogels where the stor-
age (G’) and loss (G”) moduli are independent of 
the strain amplitude.
The time dependence of the shear storage and 
loss modulus was evaluated on the in situ gelation 
of the hydrogel at shear deformation of 1 % and an 
angular frequency of ω = 1.26 rad s–1 for 20 min to 
determine the influence of HAp content on gelation 
time of hydrogels.
A constant strain (1 %) frequency sweep test 
within the angular frequency range of 0.1 – 800 rad s–1 
was performed on the in situ crosslinked hydrogels 
to determine the mechanical properties of the differ-
ent hydrogels.
Cytotoxicity of hydrogels
The cytotoxicity of composite hydrogels was 
determined using 3-(4,5-dimethylthiazol-2-yl)-2,5- 
-diphenyltetrazolium bromide (MTT) assay on 
 human embryonic kidney (Hek293) cell line. Prior 
to the assay, samples were disinfected with penicil-
lin/streptomycin and antifungal agent (3 %) for 2 h 
at 4 °C. After disinfection, samples were washed 
three times in DPBS (Dulbecco’s phosphate saline, 
pH 7.4), and subsequently incubated with culture 
medium (DMEM) supplemented with 10 % of fetal 
bovine serum (FBS) and 1 % of penicillin/strepto-
mycin (P/S) for 24 h at 4 °C.
Meanwhile, Hek293 cells were seeded in a 
 96-well plate (Sarsted) in triplicates at a density of 
3 · 103 cells/200 mL, and grown in Dulbecco’s mod-
ified Eagle medium with 4500 mg L–1 glucose 
(DMEM-high glucose, Lonza) containing 10 % 
 fetal bovine serum (FBS, Gibco), 100 U mL–1 peni-
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cillin, and 100 mg mL–1 streptomycin (Sigma- 
Aldrich). After 1 day of culture, medium was re-
placed with extract from the samples, and incubated 
for next 3 days in 5 % CO2 humidified atmosphere 
at 37 °C. Following the incubation period of 24 and 
72 h, respectively, the medium was aspirated and 
200 mL of MTT (Sigma-Aldrich) was added to each 
well at a concentration of 0.5 mg mL–1. After 4 h of 
incubation at 37 °C, MTT was aspirated and for-
mazan crystals were dissolved by adding 170 mL of 
DMSO to each well. After 1 h at room temperature, 
100 mL of solution per well was transferred into 
clean 96-well plate to measure the absorbance on a 
microplate reader (Promega) at 570 nm. The cell vi-
ability was calculated with respect to the control 
(non-treated cells).
Statistical analysis of data
All experiments were performed in triplicate, 
and results are expressed as mean value corrected 
by the standard deviation. Statistical analysis of the 
data was carried out by one-way ANOVA test. Sta-
tistical significance between two groups was con-
sidered at a p < 0.05.
Results and discussion
Materials identification
The grafting of tyramine onto the gelatine mac-
romolecules was verified using 1H-NMR analysis. 
The presence of distinctive peaks for both aromatic 
ring protons (at 7.0 and 6.7 pmm) in Gel-Tyr spec-
trum indicated successful grafting (data not shown). 
This indication was also confirmed by the UV spec-
trophotometry with 1.9·10–7 tyramine grafted groups 
per mg of gelatin4. The same gelatine was used in 
this study to prepare Gel-Tyr/HAp composite hy-
drogels.
The prepared gelatine-tyramine/hydroxyapatite 
(Gel-Tyr/HAp) composites and hydroxyapatite par-
ticles as a control material were characterised by 
FTIR and XRD analyses.
The absorption bands specific for the modified 
gelatine and hydroxyapatite are depicted in Fig. 2. 
The characteristic phosphate bands of hydroxyapa-
tite control are found at 1029 cm–1, which corre-
sponds to the asymmetric stretching, band at 962 
cm–1 assigned to the symmetric stretching and bands 
at 599 and 561 cm–1 were attributed to asymmetric 
bending vibrations of the PO4
3– group9. The absorp-
tion bands specific for carbonate groups found at 
1450 and 1421 cm–1 indicate the B-type substitution 
of CO3
2– ions in hydroxyapatite structure. More-
over, the band at 873 cm–1 (HPO4
2– group) also indi-
cates the formation of non-stoichiometric calci-
um-deficient hydroxyapatite (Ca/P ≠ 1.67) with 
proposed structure Ca10–x(HPO4)x(PO4)6–x(OH)2–x
10,11. 
Stoichiometric HAp (Ca/P = 1.67) is the most used 
calcium phosphate in the development of bone tis-
sue substitute materials12. However, its stoichiome-
try favours high thermal and chemical stability, 
which mostly results in slow bioresorption under 
physiological conditions. Natural bone tissue pos-
sesses calcium phosphates substituted with different 
monovalent and divalent cations and anions (Na+, 
K+, Mg2+, Sr2+, HCO3
–, CO3
2–, HPO4
–, F–). Carbonate 
ions are crucial in metabolic processes during for-
mation of new bone, promoting faster calcium and 
phosphate diffusion from the hydroxyapatite lattice 
that are necessary in the later stage of bone miner-
alisation. Bearing this in mind, synthesized CO3
2– 
substituted hydroxyapatite would show greater bio-
activity and osteoconductivity under in vivo 
conditions than stoichiometric apatite.
The composite systems prepared with 2, 5, and 
10 % of HAp show characteristic phosphate bands 
at 1029, 597 and 559 cm–1 with a slight shift of the 
phosphate asymmetric bending vibrations. Such 
phenomenon could indicate possible electrostatic 
interactions between in situ precipitated HAp and 
functional groups of gelatine-tyramine. As seen 
from Fig. 2, the intensity of phosphate bands in-
creases with the amount of in situ formed HAp, 
with the strongest intensities found in the 10 % 
HAp composite.
Apart from the characteristic HAp absorption 
bands, the composite hydrogels possess absorption 
bands specific for the gelatine matrix: amino (N–H) 
band at wave number range of 3270 – 3370 cm–1, 
absorption band associated with C–H stretching at 
2947 cm–1, and characteristic amide bands at 1637 
cm–1 (–C=O) and 1540 cm–1 (N–H). Absorption band 
at 1450 cm–1 corresponds to carbonyl bond of ion-
ised –COO– group13. Mentioned absorption bands of 
gelatine were also found in the composite hydrogels 
with a slight shift of the C=O asymmetric stretching 
vibration from 1637 to 1633 cm–1, and the carboxyl-
ic group from 1452 to 1448 cm–1 observed in the 
composite with the highest HAp content. This could 
be a result of specific complexation reactions in-
volving calcium ions from apatite and carboxylic 
(–COO–)/carbonyl group of gelatine. The complex-
ation of calcium and carboxyl groups during in situ 
apatite formation has been reported in pectin matri-
ces as a possible route for nucleation of hydroxyap-
atite crystals14. As a result, nanostructured materials 
with good crystal dispersion can be formed.
The mineralogical composition of composite 
systems and control materials was studied by X-ray 
diffraction analysis and identified using ICDD 
(International Centre for Diffraction Data) card cat-
alogue. The XRD patterns of investigated materials 
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are given in Fig. 3. According to the standard card 
(ICDD 9-432), control material shows hydroxyapa-
tite as only inorganic phase indicated by diffraction 
maxima at 2q = 25.9° (002), 31.9° (211), 39.7° 
(310), 46.6° (222), 49.4° (213) and 53.4° (004). The 
broadening of diffraction maxima of HAp patterns 
suggests low crystallinity, which plays an important 
role during bioresorption processes. On the other 
hand, amorphous structure of gelatine-tyramine was 
observed by broad diffraction maxima at 2θ = 7.2, 
8.5 and 21.2°. These characteristic diffraction max-
ima are usually assigned to the triple-helical crystal-
line structure in collagen and gelatin15.
F i g .  2  – FTIR spectra of gelatine-tyramine (Gel-Tyr), hydroxyapatite (HAp) and Gel-Tyr/
HAp composites with different HAp content (2 % HAp, 5 % HAp, and 10 % HAp)
F i g .  3  – Diffraction patterns of gelatine (Gel-Tyr), hydroxyapatite (HAp) and Gel-Tyr/HAp 
composites with different HAp content (2 % HAp, 5 % HAp, and 10 % HAp)
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XRD diffraction patterns of in situ formed 
composite hydrogel show superposition of diffrac-
tion peaks corresponding to hydroxyapatite and gel-
atine-tyramine. The apatite phase is indicated by the 
strongest diffraction maximum at 2θ = 31.9°, which 
is clearly observable in Gel-Tyr/HAp with 10 % of 
hydroxyapatite. A broader maximum of hydroxyap-
atite within gelatine indicates low crystallinity of in 
situ precipitated inorganic phase, which could be a 
result of specific complexation, i.e., nucleation by 
the carboxylic/carbonyl group. Smaller hydroxyap-
atite crystals can impact the protein adsorption onto 
artificial material, which finally dictates cell adhe-
sion during in vitro and in vivo tissue formation. 
Besides, the crystalline size can also impact the rate 
of dissolution and bioresorption of the material. 
Having smaller HAp crystals, Gel-Tyr/HAp hydro-
gels could positively influence the cell attachment. 
The lower intensity of 2θ = 31.9° in 2 % and 5 % of 
HAp in composite hydrogels could be due to lower 
apatite content.
Morphology of hydrogels
In order to observe the morphology and distri-
bution of HAp within the gelatine, the cross-section 
of lyophilised hydrogels was imaged by SEM. The 
micrographs of cross-section of pure gelatine (Gel-
Tyr) and different composite hydrogels are depicted 
in Fig. 4.
All hydrogels exhibit a layered structure with-
out defined pores size or shape which results from 
the formation of water crystals during freezing. 
Pure gelatine-tyramine is characterised by smooth 
surface, while the addition of hydroxyapatite result-
ed in smaller or larger particles or crystals agglom-
eration. The lowest amount of HAp (2 % HAp) 
shows small agglomerates, consisting of plate-like 
crystals (indicated with red arrows), concentrated 
on some parts of the gelatine matrix. The increase 
in apatite content favours the formation of larger 
plate-like agglomerates which are homogeneously 
distributed throughout the gelatine matrix (5 % 
HAp) with respect to other composites. The highest 
amount of HAp (10 % HAp) led to the formation of 
characteristic cauliflower morphology consisting of 
petal-like crystal agglomerates emerging from the 
gelatine and concentrated on the edges of ‘polymer 
sheets’. Dispersion of hydroxyapatite crystals with-
in gelatine matrix depends on the quantity of calci-
um and phosphate precursors, stirring speed, pH of 
reaction mixture, physicochemical properties of 
polymer solution, etc.16 The viscosity of gelatine 
solution is very low; therefore, it was difficult to 
obtain stable gelatine/HAp composites at higher 
HAp quantity. Hydroxyapatite crystals are of nano-
metric sizes and tend to agglomerate. At physiolog-
ical pH, as it was for reaction mixture, crystals form 
specific petal-like or cauliflower structure, i.e., ag-
glomerates. The larger agglomerates with size of 
approximately 10 mm were formed as a result of 
the crystal growth provided by the higher concen-
tration of phosphate and calcium ions. Such mor-
phology of in situ synthesized hydroxyapatite has 
been previously reported in chitosan-HAp based 
systems17. However, the application of injectable 
hydrogels considers utilization of small-gauge nee-
dles. The smaller inorganic particles guarantee the 
efficient injection of such hydrogel18. Comparing 
the investigated composites, 5 % of HAp seems to 
have better distribution of HAp agglomerates 
through gelatine matrix, as seen from SEM micro-
graphs.
F i g .  4  – SEM micrographs of gelatine (Gel-Tyr) and Gel-Tyr/
HAp composites with different HAp content (2 % HAp, 5 % 
HAp, and 10 % HAp)
332 A. Rogina et al., Bone-Mimicking Injectable Gelatine/Hydroxyapatite Hydrogels, Chem. Biochem. Eng. Q., 33 (3) 325–335 (2019)
Swelling ability
The ability of the hydrogel to absorb water was 
proved to have a great impact on the mechanical 
stability under load and diffusion of cell nutrient 
during in vitro culture. Swelling behaviour of the 
hydrogels is closely related to its porosity and cross-
linking degree. The swelling capacity decreases 
with increasing crosslink density19 and can be al-
tered by the incorporation of different inorganic or 
polymer particles with different hydrophilicity.
All hydrogels show high swelling ability with 
equilibrium water content higher than 3000 % (Fig. 
5). The largest water uptake is noted for pure ge-
latine-tyramine (Gel-Tyr) hydrogel with value of 
~4500 %. Although hydroxyapatite favours water 
adsorption, swelling ratio was lowered by the in-
corporation of HAp down to approximately 3500 % 
for all Gel-Tyr/HAp hydrogels. This could be a 
 consequence of hindered carbonyl/carboxylic 
groups of gelatine chains by in situ formed hy-
droxyapatite particles, thus affecting the hydrogel’s 
hydrophilicity.
F i g .  5  – Equilibrium water content (EWC) of gelatine (Gel-
Tyr) and Gel-Tyr/HAp composites with different HAp content (2 
% HAp, 5 % HAp, and 10 % HAp). Significant difference be-
tween two groups is denoted by asterisk (*).
F i g .  6  – Rheological properties of gelatine (Gel-Tyr) and Gel-Tyr/HAp composites with different HAp content (2 % HAp, 5 % HAp, 
and 10 % HAp): a) gel formation was monitored by time sweep evaluating the storage and loss moduli as functions of time at 1 % 
strain; b) frequency sweep data at a constant strain of 1 %. Figure represents curves obtained from average data of three individual 
samples. Relative standard deviations of storage modulus are not included for the sake of clarity.
(a)
(b)
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Rheological behaviour of hydrogels
The shear strength of crosslinked hydrogels 
was evaluated within linear viscoelastic range to en-
sure their stability20. The strain amplitude test, 
where shear storage and loss modulus are indepen-
dent of the applied shear stress, showed gel stability 
up to 15 % strain (data not shown). Subsequent 
 rheological measurements (Fig. 6) were obtained at 
1 % strain to ensure linear viscoelastic region free 
of noise interference.
The gelation time of the injectable hydrogels 
was evaluated by the time sweep test at 25 °C. The 
time of crosslink of Gel-Tyr and Gel-Tyr/HAp was 
determined as a cross-section where interpolation of 
initial and ending regions of storage modulus–time 
curve meet21. The enzymatically-crosslinked hydro-
gels are characterised by their fast gelation up to a 
few minutes. All hydrogels were almost completely 
crosslinked between 3.3 and 4.5 min (Table 1), after 
which storage modulus rose slightly (Fig. 6a). After 
1200 s of sweep test, the storage modulus reached a 
plateau. The hydrogel with 5 % HAp seems to have 
minimum impact on gelation rate regarding pure 
Gel-Tyr hydrogel. Nonetheless, all prepared com-
posite hydrogels gelate quickly, which is eligible in 
clinical practice.
The frequency sweep experiments (Fig. 6b) 
were carried out to investigate the gel properties of 
the cured systems, namely, the stability of three-di-
mensional crosslinked networks. No change was 
found in the storage modulus until 10 rad s–1; how-
ever, it increased after 10 – 20 rad s–1 depending on 
the hydrogel’s composition. At 1 % strain, the shear 
strength of hydrogels increased almost linearly with 
higher HAp content (up to 5 % of HAp) indicating 
possible reinforcement of the gelatine-tyramine ma-
trix. An unexpected behaviour was observed for the 
hydrogel with 10 % of HAp that has a lower storage 
modulus than the hydrogel with 5 % HAp, and of 
the order of magnitude of the 2 % HAp hydrogel 
(Table 1). Hydrogel mechanical properties depend 
on multiple parameters, such as porosity, swelling 
ability, rigidity of molecular chain, and additional 
fillers. Since there was no significant difference in 
the swelling capacity of the different Gel-Tyr/HAp 
hydrogels, the decrease in the mechanical properties 
of the 10 % HAp composite can be attributed to the 
non-uniform concentration of larger HAp agglom-
erates (as shown in Fig. 4). The limited reinforce-
ment ability of HAp was previously reported on dry 
polymer/HAp systems as well as for composite hy-
drogels where increase in HAp amount weakened 
the mechanical properties22–24. The evaluation of 
compressive and tensile strength of chitosan/HAp 
porous structures in wet state24 showed the initial 
reinforcement of composite when incorporated 
amount of HAp was low, followed by a decrease in 
strength at higher HAp content. Similar behaviour 
was reported on injectable n-HAp/(PEG-PCL-PEG) 
hydrogel, where rheological evaluation showed de-
crease in storage modulus when HAp was loaded 
above 20 %25. The same trend was observed in this 
study; however, at lower range of HAp content than 
found in the literature. As seen from morphology 
imaging, 5 % of HAp could be the critical quantity 
for better dispersion of smaller crystal agglomerates 
that positively influenced mechanical behaviour of 
the composite hydrogel.
Cytotoxicity of hydrogels
The cytotoxicity assay is an easy test to deter-
mine whether investigated biomaterials are toxic for 
living cells. High cell viability (over 60 %) indi-
cates non-cytotoxicity of the materials, i.e., good 
cell spreading and survival. Fig. 7 depicts high cell 
viability of Hek293 cells cultured in the materials’ 
extracts with respect to the non-treated cells. More-
over, cell proliferation continued for 3 days of cul-
ture, indicating favourable composition of compos-
ite hydrogel with 5 % of HAp.
Conclusion
Gelatine and hydroxyapatite are frequently 
used components for development of potential bone 
tissue grafts due to their biocompatibility, biodegra-
dation, and osteoinductivity. In this work, injectable 
composite hydrogels based on tyramine-modified 
gelatine and in situ synthesized apatite have been 
prepared and characterised. In situ synthesis of hy-
droxyapatite led to the formation of different sizes 
of particles consisting of nano-scale crystals distrib-
Ta b l e  1  – Gelation time, storage, and loss modulus of different hydrogels evaluated at an angular frequency of 1.26 rad s–1 using 1 
% of strain at 25 °C. The values represent the average of three individual experiments.
Hydrogel Gelation time (s) Shear storage modulus (Pa) Shear loss modulus (Pa) tan δ
Gel-Tyr 212.4 ± 2.5 822.7 ± 32.6 1.2 ± 0.0 1.5 · 10–3
2 % HAp 269.8 ± 32.9 942.1 ± 80.3 2.0 ± 0.9 2.1 · 10–3
5 % HAp 209.3 ± 0.4 1098.6 ± 54.0 2.5 ± 0.5 2.3 · 10–3
10 % HAp 272.6 ± 13.7 984.3 ± 42.5 0.7 ± 0.2 7.1 · 10–4
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uted through gelatine matrix. Depending on the 
HAp quantity, mechanical properties of hydrogel 
could be improved in terms of shear storage modu-
lus. The composite consisting of 5 % HAp pos-
sessed the highest increase in shear modulus with-
out significant influence on the gelation time, which 
could be due to better distribution of smaller HAp 
agglomerates with respect to other systems. Addi-
tionally, the lack of toxicity of prepared injectable 
hydrogels shows good potential for further investi-
gation of biological properties in terms of their bio-
activity and osteoinductivity.
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